Evaluation of Specimen Types and Saliva Stabilization Solutions for SARS-CoV-2 Testing
Sara B. Griesemer, Greta Van Slyke, Dylan Ehrbar, Klemen Strle, Tugba Yildirim, Dominick A. Centurioni, Anne C. Walsh, Andrew K. Chang, Michael Waxman, Kirsten St. George
Abstract
= 227) had a positivity rate of 41%, with sensitivity in NPS, NS, and saliva of 97.9%, 87.1%, and 87.1%, respectively. Whether the reduced sensitivity of NS or saliva is acceptable must be assessed in the settings where they are used. However, we sought to improve on it by validating a method to mix the two sample types, as the combination of nasal swab and saliva resulted in 94.6% SARS-CoV-2 detection sensitivity. Spiking experiments showed that combining them did not adversely affect the detection sensitivity in either. Virus stability in saliva was also investigated, with and without the addition of commercially available stabilizing solutions. The virus was stable in saliva at both 4°C and room temperature for up to 7 days. The addition of stabilizing solutions did not enhance stability and, in some situations, reduced detectable virus levels.